Literature DB >> 9072379

Acceleration of renal disease in obese SHR by exacerbation of hypertension.

R J Koletsky1, J Boccia, P Ernsberger.   

Abstract

1. Obese SHR have lower blood pressures than lean littermates on ad libitum diets of standard rat chow and develop spontaneous progressive kidney disease with marked proteinuria, whereas lean SHR have only mild proteinuria. 2. On a high-salt diet, obese SHR show dramatic elevations in blood pressure accompanied by accelerated renal disease and mortality. Lean SHR are also salt sensitive but to a lesser degree. 3. Weight cycling elevates blood pressure in obese SHR to levels comparable to lean SHR littermates. This elevation in blood pressure is accompanied by an exacerbation of kidney disease relative to age-matched controls. 4. Ganglionic blockade reversed the elevation in blood pressure in obese SHR elicited by either high-salt diet or weight cycling. Therefore, excess sympathetic nervous activity contributes to the impact of these hypertensive stimuli. 5. Exacerbation of hypertension accelerates renal disease in obese SHR.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9072379     DOI: 10.1111/j.1440-1681.1995.tb02905.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol Suppl        ISSN: 0143-9294


  5 in total

1.  Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome.

Authors:  Paul Ernsberger; Janean L Johnson; Talma Rosenthal; David Mirelman; Richard J Koletsky
Journal:  Am J Hypertens       Date:  2007-08       Impact factor: 2.689

2.  Urinary biomarkers track the progression of nephropathy in hypertensive and obese rats.

Authors:  Qin Zhang; Kelly J Davis; Dana Hoffmann; Vishal S Vaidya; Ronald P Brown; Peter L Goering
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

3.  Sympathetic nervous system in salt-sensitive and obese hypertension: amelioration of multiple abnormalities by a central sympatholytic agent.

Authors:  P Ernsberger; R J Koletsky; L A Collins; D Bedol
Journal:  Cardiovasc Drugs Ther       Date:  1996-06       Impact factor: 3.727

Review 4.  Combating Combination of Hypertension and Diabetes in Different Rat Models.

Authors:  Talma Rosenthal; Firas Younis; Ariela Alter
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-26

5.  Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.

Authors:  Barbora Mikulášková; Martina Holubová; Veronika Pražienková; Jana Zemenová; Lucie Hrubá; Martin Haluzík; Blanka Železná; Jaroslav Kuneš; Lenka Maletínská
Journal:  Nutr Diabetes       Date:  2018-01-16       Impact factor: 5.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.